PURPOSE To report the long-term clinical outcomes, including efficacy and safety, of implantable collamer lens (ICL) implantation to treat myopia. SETTING Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. DESIGN Retrospective case series. METHODS Medical records of patients who had ICL implantation were reviewed. The preoperative and postoperative visual acuity, spherical equivalent (SE), endothelial cell density (ECD), and intraocular pressure (IOP) were analyzed. The postoperative vault and complication rate, including cataract and glaucoma, were evaluated. Patients were placed in the lens opacity group or clear lens group based on whether lens opacity developed postoperatively. RESULTS One hundred ten eyes (60 patients) were analyzed. The mean preoperative age was 30.3 years ± 8.3 (SD). The mean SE was -12.01 ± 3.70 diopters (D) preoperatively and -0.65 ± 1.09 D 10 years postoperatively. The mean vault height was 562.4 ± 175.9 μm 6 months postoperatively, decreasing to 352.9 ± 171.8 μm at 10 years. There were no significant changes in the ECD and IOP at any timepoint. Lens opacities developed in 21 eyes (12.1%) during the 10-year follow-up. The mean vault in the lens opacity group was significantly lower than in the clear lens group after 4 years. No patient who had ICL implantation when they were 30 years or younger developed lens opacity or required phacoemulsification. CONCLUSIONS The results indicate that ICL implantation provided long-term stability and good refractive outcomes. Performing this surgery in young patients, especially those 30 years or younger, may be safe in terms of long-term cataract formation.

中文翻译：

---

植入后房近视眼人工晶状体用于近视后的十年临床结果。

目的报告可植入式散光镜（ICL）植入治疗近视的长期临床结果，包括疗效和安全性。地点韩国成均馆大学医学院三星医学中心眼科。设计回顾案系列。方法回顾了ICL植入患者的病历。术前和术后视力，球当量（SE），内皮细胞密度（ECD）和眼内压（IOP）进行了分析。评估术后穹ault和并发症发生率，包括白内障和青光眼。根据术后是否发生晶状体混浊，将患者分为晶状体混浊组或透明晶状体组。结果分析了一百零一只眼（60例患者）。术前平均年龄为30岁。3年±8.3（标准差）。术前平均SE为-12.01±3.70屈光度（D），术后10年为-0.65±1.09D。术后六个月的平均穹顶高度为562.4±175.9μm，十年后降至352.9±171.8μm。在任何时候，ECD和IOP都没有重大变化。在10年的随访中，有21眼（12.1％）出现了晶状体混浊。晶状体混浊组的平均穹顶在4年后显着低于透明晶状体组。30岁以下的ICL植入患者均未出现晶状体混浊或需要超声乳化。结论结果表明ICL植入提供了长期的稳定性和良好的屈光结果。在年轻患者（尤其是30岁或更年轻的患者）中进行这项手术，